IVRO — InVitro International Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $1.64m
- $1.27m
- $0.72m
Annual income statement for InVitro International, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2006 September 30th | 2007 September 30th | 2008 September 30th | 2009 September 30th | 2010 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PRESS | PRESS | PRESS | PRESS | PRESS |
Standards: | — | — | — | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.609 | 0.742 | 0.697 | 0.756 | 0.717 |
Other Operating Expenses | |||||
Total Operating Expenses | 0.598 | 0.68 | 0.64 | 0.713 | 0.73 |
Operating Profit | 0.011 | 0.061 | 0.056 | 0.042 | -0.013 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.016 | 0.069 | 0.065 | 0.051 | 0.006 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.016 | 0.069 | 0.065 | 0.051 | 0.006 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.016 | 0.069 | 0.065 | 0.051 | 0.006 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.016 | 0.069 | 0.065 | 0.051 | 0.006 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | 0.004 | 0.004 | 0.003 | 0 |